{"id":"https://openalex.org/W4322744690","doi":"https://doi.org/10.3389/fphar.2023.968106","title":"Efficacy and safety of praziquantel preventive chemotherapy in Schistosoma mansoni infected school children in Southern Ethiopia: A prospective cohort study","display_name":"Efficacy and safety of praziquantel preventive chemotherapy in Schistosoma mansoni infected school children in Southern Ethiopia: A prospective cohort study","publication_year":2023,"publication_date":"2023-03-01","ids":{"openalex":"https://openalex.org/W4322744690","doi":"https://doi.org/10.3389/fphar.2023.968106","pmid":"https://pubmed.ncbi.nlm.nih.gov/36937860","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10014719"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2023.968106","doi":"https://doi.org/10.3389/fphar.2023.968106","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2023.968106","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2023.968106/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fphar.2023.968106/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075445279","display_name":"Tigist Dires Gebreyesus","orcid":"https://orcid.org/0000-0002-8969-9916","observed_orcids":["https://orcid.org/0000-0002-8969-9916"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]},{"id":"https://openalex.org/I4405262072","display_name":"Ethiopian Food and Drug Authority","ror":"https://ror.org/01791bq50","country_code":"ET","type":"government","lineage":["https://openalex.org/I4405262072"]}],"countries":["ET","SE"],"is_corresponding":false,"raw_author_name":"Tigist Dires Gebreyesus","raw_affiliation_strings":["Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden","Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia","institution_ids":["https://openalex.org/I4405262072"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022301113","display_name":"Eyasu Makonnen","orcid":"https://orcid.org/0000-0002-9259-5288","observed_orcids":["https://orcid.org/0000-0002-9259-5288"]},"institutions":[{"id":"https://openalex.org/I4537092","display_name":"Addis Ababa University","ror":"https://ror.org/038b8e254","country_code":"ET","type":"education","lineage":["https://openalex.org/I4537092"]}],"countries":["ET"],"is_corresponding":false,"raw_author_name":"Eyasu Makonnen","raw_affiliation_strings":["Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia","Departments of Pharmacology and Clinical Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia","institution_ids":["https://openalex.org/I4537092"]},{"raw_affiliation_string":"Departments of Pharmacology and Clinical Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia","institution_ids":["https://openalex.org/I4537092"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092238449","display_name":"Tafese Tadele","orcid":"https://orcid.org/0009-0008-2894-6021","observed_orcids":["https://orcid.org/0009-0008-2894-6021"]},"institutions":[{"id":"https://openalex.org/I193649603","display_name":"Hawassa University","ror":"https://ror.org/04r15fz20","country_code":"ET","type":"education","lineage":["https://openalex.org/I193649603"]}],"countries":["ET"],"is_corresponding":false,"raw_author_name":"Tafesse Tadele","raw_affiliation_strings":["College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Medicine and Health Sciences, Hawassa University, Hawassa, Ethiopia","institution_ids":["https://openalex.org/I193649603"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040783567","display_name":"Kalkidan Mekete","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098092","display_name":"Ethiopian Public Health Institute","ror":"https://ror.org/00xytbp33","country_code":"ET","type":"facility","lineage":["https://openalex.org/I4210098092"]}],"countries":["ET"],"is_corresponding":false,"raw_author_name":"Kalkidan Mekete","raw_affiliation_strings":["Ethiopian Public Health Institute, Addis Ababa, Ethiopia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ethiopian Public Health Institute, Addis Ababa, Ethiopia","institution_ids":["https://openalex.org/I4210098092"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067158480","display_name":"Habtamu Gashaw","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405262072","display_name":"Ethiopian Food and Drug Authority","ror":"https://ror.org/01791bq50","country_code":"ET","type":"government","lineage":["https://openalex.org/I4405262072"]}],"countries":["ET"],"is_corresponding":false,"raw_author_name":"Habtamu Gashaw","raw_affiliation_strings":["Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia","institution_ids":["https://openalex.org/I4405262072"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076258764","display_name":"Heran Gerba","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405262072","display_name":"Ethiopian Food and Drug Authority","ror":"https://ror.org/01791bq50","country_code":"ET","type":"government","lineage":["https://openalex.org/I4405262072"]}],"countries":["ET"],"is_corresponding":false,"raw_author_name":"Heran Gerba","raw_affiliation_strings":["Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ethiopian Food and Drug Authority, Addis Ababa, Ethiopia","institution_ids":["https://openalex.org/I4405262072"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041138412","display_name":"Eleni Aklillu","orcid":"https://orcid.org/0000-0002-9788-0790","observed_orcids":["https://orcid.org/0000-0002-9788-0790"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Eleni Aklillu","raw_affiliation_strings":["Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden","institution_ids":["https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5041138412"],"corresponding_institution_ids":["https://openalex.org/I28166907"],"apc_list":{"value":3295,"currency":"USD","value_usd":3295},"apc_paid":{"value":2688,"currency":"EUR","value_usd":2899},"fwci":4.557,"has_fulltext":true,"cited_by_count":20,"citation_normalized_percentile":{"value":0.96107968,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"14","issue":null,"first_page":"968106","last_page":"968106"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10695","display_name":"Parasites and Host Interactions","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2405","display_name":"Parasitology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10695","display_name":"Parasites and Host Interactions","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2405","display_name":"Parasitology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11702","display_name":"Parasitic Diseases Research and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12234","display_name":"Mollusks and Parasites Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1103","display_name":"Animal Science and Zoology"},"field":{"id":"https://openalex.org/fields/11","display_name":"Agricultural and Biological Sciences"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/praziquantel","display_name":"praziquantel","score":0.9110000133514404},{"id":"https://openalex.org/keywords/schistosoma-mansoni","display_name":"Schistosoma mansoni","score":0.921999990940094},{"id":"https://openalex.org/keywords/schistosomiasis","display_name":"schistosomiasis","score":0.9079999923706055},{"id":"https://openalex.org/keywords/preventive-chemotherapy","display_name":"preventive chemotherapy","score":0.9259999990463257},{"id":"https://openalex.org/keywords/mass-drug-administration","display_name":"mass drug administration","score":0.9750000238418579},{"id":"https://openalex.org/keywords/albendazole","display_name":"albendazole","score":0.9139999747276306},{"id":"https://openalex.org/keywords/elementary-school-students","display_name":"elementary school students","score":0.7689999938011169},{"id":"https://openalex.org/keywords/cure-rate","display_name":"cure rate","score":0.5699999928474426},{"id":"https://openalex.org/keywords/egg-reduction-rate","display_name":"egg reduction rate","score":0.9959999918937683},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6430000066757202},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.4410000145435333},{"id":"https://openalex.org/keywords/southern-ethiopia","display_name":"southern Ethiopia","score":0.5090000033378601},{"id":"https://openalex.org/keywords/reinfection","display_name":"reinfection","score":0.5239999890327454},{"id":"https://openalex.org/keywords/kato-katz-thick-smear","display_name":"Kato-Katz thick smear","score":0.699999988079071}],"concepts":[{"id":"https://openalex.org/C2779744950","wikidata":"https://www.wikidata.org/wiki/Q424145","display_name":"Praziquantel","level":4,"score":0.9659275412559509},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8055781126022339},{"id":"https://openalex.org/C2776863245","wikidata":"https://www.wikidata.org/wiki/Q2324689","display_name":"Schistosoma mansoni","level":4,"score":0.7672207355499268},{"id":"https://openalex.org/C2777065887","wikidata":"https://www.wikidata.org/wiki/Q411629","display_name":"Albendazole","level":2,"score":0.7591702938079834},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6244440674781799},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5225679278373718},{"id":"https://openalex.org/C2778491710","wikidata":"https://www.wikidata.org/wiki/Q1457418","display_name":"Schistosoma","level":5,"score":0.5091215968132019},{"id":"https://openalex.org/C2780133432","wikidata":"https://www.wikidata.org/wiki/Q6784028","display_name":"Mass drug administration","level":3,"score":0.5052016377449036},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.4980742931365967},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.4620921015739441},{"id":"https://openalex.org/C2776225656","wikidata":"https://www.wikidata.org/wiki/Q221159","display_name":"Schistosomiasis","level":3,"score":0.46116939187049866},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3756217062473297},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3050570785999298},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24381223320960999},{"id":"https://openalex.org/C165901193","wikidata":"https://www.wikidata.org/wiki/Q3129936","display_name":"Helminths","level":2,"score":0.1536039412021637},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.14971479773521423},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.06831017136573792}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2023.968106","doi":"https://doi.org/10.3389/fphar.2023.968106","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2023.968106","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2023.968106/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10014719","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10014719","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10014719/pdf/fphar-14-968106.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmid:36937860","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36937860","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:eb0b8e46757146acadf48c614d6595ed","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/eb0b8e46757146acadf48c614d6595ed","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 14 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2023.968106","doi":"https://doi.org/10.3389/fphar.2023.968106","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2023.968106","pdf_url":"https://www.frontiersin.org/articles/10.3389/fphar.2023.968106/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2644651030","display_name":null,"funder_award_id":"CSA2016S-1618","funder_id":"https://openalex.org/F4320307875","funder_display_name":"Styrelsen f\u00f6r Internationellt Utvecklingssamarbete"},{"id":"https://openalex.org/G5221540170","display_name":"Pharmacovigilance infrastructure and post-marketing surveillance system capacity building for regional medicine regulatory harmonization in East Africa","funder_award_id":"CSA2016S-1618","funder_id":"https://openalex.org/F4320338462","funder_display_name":"European and Developing Countries Clinical Trials Partnership"}],"funders":[{"id":"https://openalex.org/F4320307875","display_name":"Styrelsen f\u00f6r Internationellt Utvecklingssamarbete","ror":"https://ror.org/01fn7me06"},{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320325948","display_name":"Hawassa University","ror":"https://ror.org/04r15fz20"},{"id":"https://openalex.org/F4320338462","display_name":"European and Developing Countries Clinical Trials Partnership","ror":"https://ror.org/031jv9v19"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4322744690.pdf","grobid_xml":"https://content.openalex.org/works/W4322744690.grobid-xml"},"referenced_works_count":37,"referenced_works":["https://openalex.org/W412512817","https://openalex.org/W779721803","https://openalex.org/W1561881988","https://openalex.org/W1982014440","https://openalex.org/W1988963904","https://openalex.org/W1993867737","https://openalex.org/W2016150993","https://openalex.org/W2045121392","https://openalex.org/W2066483046","https://openalex.org/W2074337670","https://openalex.org/W2079682170","https://openalex.org/W2127662192","https://openalex.org/W2130167904","https://openalex.org/W2139638211","https://openalex.org/W2144885469","https://openalex.org/W2497850966","https://openalex.org/W2581862160","https://openalex.org/W2594312336","https://openalex.org/W2625578425","https://openalex.org/W2751884637","https://openalex.org/W2759454245","https://openalex.org/W2783986784","https://openalex.org/W2904825762","https://openalex.org/W2906176059","https://openalex.org/W3000230954","https://openalex.org/W3005271998","https://openalex.org/W3081850914","https://openalex.org/W3088515432","https://openalex.org/W3095574290","https://openalex.org/W3133282602","https://openalex.org/W3134129816","https://openalex.org/W3137604237","https://openalex.org/W3138196229","https://openalex.org/W3175176752","https://openalex.org/W3211875717","https://openalex.org/W4280522852","https://openalex.org/W4302419854"],"related_works":["https://openalex.org/W4390011299","https://openalex.org/W2998343763","https://openalex.org/W4386814774","https://openalex.org/W2045121392","https://openalex.org/W2010157824","https://openalex.org/W3022462464","https://openalex.org/W4285020222","https://openalex.org/W4392368158","https://openalex.org/W2066446789","https://openalex.org/W2102896099"],"abstract_inverted_index":{"Background:":[0],"The":[1,87,109,195,225,263,288],"World":[2,257],"Health":[3,258],"Organization":[4,259],"recommends":[5],"efficacy":[6,95],"and":[7,29,63,89,98,102,115,122,155,203,207,240,245,249,282,293,299,325,331,333,339,349,365,373],"safety":[8,31],"surveillance":[9,366],"of":[10,22,32,65,85,227,265,271,290,321,355,370,375],"anti-helminths":[11],"used":[12],"in":[13,39,48,346,352],"mass":[14],"drug":[15,67],"administration":[16,68],"campaigns.":[17],"We":[18],"evaluated":[19],"the":[20,30,213,234,255,285,319,342,359],"effectiveness":[21,345],"single-dose":[23],"praziquantel":[24,33,72,94,314],"against":[25],"Schistosoma":[26,40,183],"mansoni":[27,41],"infection,":[28],"plus":[34],"albendazole":[35,326],"preventive":[36,327],"chemotherapy":[37,328],"(PC)":[38],"infected":[42,132,356],"school":[43],"children":[44,133,162,228,357],"(n":[45],"=":[46,120,125,139,153,177,221,277,310],"512)":[47],"Southern":[49],"Ethiopia.":[50],"Method:":[51],"Stool":[52],"examinations":[53],"were":[54,75,93,117,134,182,205,274,284],"done":[55],"using":[56],"thick":[57],"smear":[58],"Kato-Katz":[59],"at":[60,113,147,171,186,192,201,223,243,267],"baseline,":[61],"week-4,":[62],"week-8":[64,116,156,172,204,246],"post-Mass":[66],"(MDA)":[69],"to":[70,82,142],"assess":[71],"efficacy.":[73,262],"Participants":[74],"followed":[76],"for":[77,261,318,361,367],"MDA-associated":[78,103,272],"adverse":[79,104],"events":[80,105],"up":[81],"day":[83],"7":[84],"post-MDA.":[86],"primary":[88],"secondary":[90],"study":[91,235],"outcomes":[92],"(parasitological":[96],"cure":[97,111,166],"egg":[99,197],"reduction":[100,198],"rates)":[101],"(AEs),":[106],"respectively.":[107,127,301],"Result:":[108],"overall":[110,196],"rates":[112,129],"week-4":[114,148,202,244],"89.1%":[118],"(95%CI":[119,124,276],"86.1\u201391.7)":[121],"87.5%":[123],"83.6\u201390.8),":[126],"Cure":[128],"among":[130,212],"moderate-to-heavily":[131],"significantly":[135],"lower":[136,211],"(":[137,219,308],"p":[138,152,176,220,309],"0.001)":[140],"compared":[141],"those":[143,180],"with":[144],"light":[145],"infection":[146,348],"(84.4%":[149],"vs.":[150,158,174],"91.1%,":[151],"0.03)":[154],"(78.6%":[157],"91.9%,":[159],"respectively).":[160],"Older":[161],"had":[163],"a":[164],"higher":[165],"rate":[167,199],"than":[168,306],"younger":[169],"ones":[170],"(90.1%":[173],"79.5%,":[175],"0.01).":[178],"Among":[179],"who":[181,229],"egg-free":[184],"(cured)":[185],"week":[187,193],"4,":[188],"7.8%":[189],"became":[190],"egg-positive":[191,232],"8.":[194],"(ERR)":[200],"93.5%":[206],"91.3%,":[208],"respectively,":[209,251],"being":[210],"5\u20139":[214],"years":[215],"old":[216],"age":[217],"groups":[218],"0.01)":[222],"week-8.":[224],"proportion":[226,289],"remained":[230],"schistosoma":[231],"throughout":[233],"follow-up":[236],"period":[237],"was":[238,247,296],"4.6%,":[239],"their":[241],"ERR":[242],"50%":[248],"51%,":[250],"which":[252],"is":[253,315,329],"below":[254],"90%":[256],"threshold":[260],"incidence":[264],"experiencing":[266],"least":[268],"one":[269],"type":[270],"AEs":[273,295,305,335,351],"17.0%":[275],"13.8%\u201320.5%);":[278],"abdominal":[279],"pain,":[280],"headache,":[281],"vomiting":[283],"most":[286],"common.":[287],"mild,":[291],"moderate,":[292],"severe":[294],"63.2%,":[297],"26.3%,":[298],"10.5%,":[300],"Females":[302],"experienced":[303],"more":[304],"males":[307],"0.03).":[311],"Conclusion:":[312],"Single-dose":[313],"still":[316],"effective":[317],"treatment":[320,363],"intestinal":[322],"schistosomiasis.":[323],"Praziquantel":[324],"safe":[330],"tolerable,":[332],"associated":[334],"are":[336],"mostly":[337],"mild-to-moderate":[338],"transient.":[340],"However,":[341],"reduced":[343],"PZQ":[344],"moderate-to-heavy":[347],"observed":[350],"about":[353],"one-fifth":[354],"underscores":[358],"need":[360],"better":[362],"strategies":[364],"early":[368],"detection":[369],"parasite":[371],"resistance":[372],"management":[374],"AEs.":[376]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-03-03T00:00:00"}